Press releases
- Enanta Pharmaceuticals to Participate at the JMP Securities Life Sciences Conference
- Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter with Webcast and Conference Call Today at 4:30 p.m. ET
- Enanta Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Enanta Pharmaceuticals Announces the Appointment of Matthew P. Kowalsky as Chief Legal Officer
- Enanta Pharmaceuticals to Host Conference Call on May 6 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Second Quarter Ended March 31, 2024
- Enanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024
- Enanta Pharmaceuticals to Participate at Leerink Partners Global Biopharma Conference
More ▼
Key statistics
As of last trade, Enanta Pharmaceuticals Inc (9EP:STU) traded at 10.90, 42.48% above the 52 week low of 7.65 set on Nov 14, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 11.10 |
---|---|
High | 11.10 |
Low | 10.90 |
Bid | 10.90 |
Offer | 11.20 |
Previous close | 11.10 |
Average volume | 0.00 |
---|---|
Shares outstanding | 21.18m |
Free float | 19.89m |
P/E (TTM) | -- |
Market cap | 252.67m USD |
EPS (TTM) | -6.25 USD |
Data delayed at least 15 minutes, as of May 28 2024.
More ▼